BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11238563)

  • 1. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
    McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
    J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier.
    Garber JJ; Mallick EM; Scanlon KM; Turner JR; Donnenberg MS; Leong JM; Snapper SB
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):273-288. PubMed ID: 29675452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF.
    Elliott SJ; O'Connell CB; Koutsouris A; Brinkley C; Donnenberg MS; Hecht G; Kaper JB
    Infect Immun; 2002 May; 70(5):2271-7. PubMed ID: 11953359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
    Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
    Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.
    Simonovic I; Rosenberg J; Koutsouris A; Hecht G
    Cell Microbiol; 2000 Aug; 2(4):305-15. PubMed ID: 11207587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.
    Shaw RK; Cleary J; Murphy MS; Frankel G; Knutton S
    Infect Immun; 2005 Feb; 73(2):1243-51. PubMed ID: 15664974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway.
    McNamara BP; Donnenberg MS
    FEMS Microbiol Lett; 1998 Sep; 166(1):71-8. PubMed ID: 9741085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.
    Nougayrède JP; Donnenberg MS
    Cell Microbiol; 2004 Nov; 6(11):1097-111. PubMed ID: 15469437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
    Dean P; Kenny B
    Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection.
    Viswanathan VK; Lukic S; Koutsouris A; Miao R; Muza MM; Hecht G
    Cell Microbiol; 2004 Oct; 6(10):987-97. PubMed ID: 15339273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SepL, a protein required for enteropathogenic Escherichia coli type III translocation, interacts with secretion component SepD.
    O'Connell CB; Creasey EA; Knutton S; Elliott S; Crowther LJ; Luo W; Albert MJ; Kaper JB; Frankel G; Donnenberg MS
    Mol Microbiol; 2004 Jun; 52(6):1613-25. PubMed ID: 15186412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion of enteropathogenic Escherichia coli to host cells.
    Nougayrède JP; Fernandes PJ; Donnenberg MS
    Cell Microbiol; 2003 Jun; 5(6):359-72. PubMed ID: 12780774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of EPEC type III effector molecules.
    Kenny B
    Int J Med Microbiol; 2002 Feb; 291(6-7):469-77. PubMed ID: 11890546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells.
    Qin H; Zhang Z; Hang X; Jiang Y
    BMC Microbiol; 2009 Mar; 9():63. PubMed ID: 19331693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.
    Nagai T; Abe A; Sasakawa C
    J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.